Inteum Company
Links
Visible Legacy
RSS
News & Resources
Inteum Company News
Inteum Library
Subscribe
Search Results - immunotherapy
143
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Polycomb Repressive Complex 1 (PRC1) Inhibitors to Restore Immune Response in B-Cell Lymphomas
SHORT DESCRIPTION A therapeutic approach that restores MHC-II expression using PRC1 inhibitors to reactivate anti-tumor immunity in B-cell lymphomas. INVENTORS Lu Wang* Zibo Zhao * Principal Investigator NU Tech ID: NU 2025-010 IP STATUS U.S. Provisional Patent Application has been filed. THERAPEUTICS...
Published: 6/25/2026
|
Updated: 6/23/2026
|
Inventor(s):
Keywords(s):
Cancer/Oncology
,
Immunotherapy
,
Therapeutics
Category(s):
Life Sciences > Therapeutics
Peptide Linkers for Modulating Antigen Immune Response in Cancer Vaccines
SHORT DESCRIPTION A novel non-biologically derived peptide linker technology enabling precise intracellular release of vaccine antigens to enhance immune activation. NU TECH ID NU 2024-124 INVENTORS Chad Mirkin* Weinberg College of Arts and Sciences, Department of Chemistry Tanner Fink *...
Published: 6/16/2026
|
Updated: 6/16/2026
|
Inventor(s):
Keywords(s):
BIO2026
,
Cancer/Oncology
,
Immunology
,
Immunotherapy
,
Infectious disease
,
Therapeutics
,
Vaccine
Category(s):
Life Sciences > Therapeutics
Biomimetic HDL Nanoparticles for Treatment of Cancer, Immune and Inflammatory Disorders, and Cardiovascular Disease
SHORT DESCRIPTION Self-assembling biomimetic high-density lipoprotein nanoparticle (HDL NP) platform technology with a soft organic core, designed to more closely replicate key functional properties of mature human HDL for therapeutic use in cardiovascular disease, cancer, and inflammatory/immune disorders. INVENTORS Colby Thaxton* Northwestern...
Published: 6/16/2026
|
Updated: 6/16/2026
|
Inventor(s):
Keywords(s):
Atherosclerosis
,
Autoimmune disease
,
BIO2026
,
Breast cancer
,
Cancer/Oncology
,
Cardiology and Cardiovascular disease
,
Gene therapy
,
Immunology
,
Immunotherapy
,
Inflammation
,
Nanomaterials
,
Nanoparticle
,
Nanotechnology
,
Nucleic Acids
,
Platform technology
,
Prostate cancer
,
Research tool
,
Small molecule
,
Targeted therapy
,
Therapeutics
Category(s):
Life Sciences > Biomarkers & Biomedical Research Tools
,
Life Sciences > Healthcare Devices, Tools & IT
,
Life Sciences > Therapeutics
Retargetable and Metabolically Tunable CAR Cell Platforms for Durable, Antigen‑Specific Cancer Therapy
SHORT DESCRIPTION A modular
immunotherapy
platform that combines hapten‑redirectable chimeric antigen receptor (CAR) constructs with itaconate‑programmed, memory‑like immune cells to deliver safer, more durable, and tunable antigen‑specific responses across hematologic and solid tumors. NU TECH ID NU 2023-021, NU 2024-077 INVENTORS Ashima...
Published: 6/10/2026
|
Updated: 6/10/2026
|
Inventor(s):
Keywords(s):
Autoimmune disease
,
Cancer Treatment
,
Cancer/Oncology
,
Cell therapy
,
Immunology
,
Immunotherapy
,
Inflammation
,
Leukemia
,
Lymphoma
,
Targeted therapy
,
Therapeutics
Category(s):
Life Sciences > Therapeutics
Open-Top Vascularized Tumor Microdevice
An open-top microfluidic chip enables transplantation of human solid tumor explants into vascularized 3D tissue for controlled CAR-T perfusion, imaging, and analysis. Tech Title: Technology: Technology: The invention includes an open-top microfluidic chip with a primary channel and adjacent side channel(s) separated by a barrier, plus apertures providing...
Published: 6/3/2026
|
Updated: 5/29/2026
|
Inventor(s):
Dongeun (dan) Huh
,
Haijiao Liu
Keywords(s):
Immunotherapy
,
Software
Category(s):
Technology Classifications > Medical Devices
,
Technology Classifications > Research Tools & Reagents
A Method for treating TNF-α-driven pathologies via Fn14 inhibition
https://wsu.technologypublisher.com/files/sites/ncs_3618.pdf
Published: 5/12/2026
|
Updated: 5/12/2026
|
Inventor(s):
Salah-uddin Ahmed
,
Farheen Shaikh
Keywords(s):
anti-inflammatory
,
Immunotherapy
,
small molecule
,
Therapeutics
Category(s):
Technologies > Health & Well-being > Chemistry
Precise, Efficient Delivery of mRNA Medicine to the Placenta
Using tiny lipid nanoparticles (LNPs) to improve mRNA medicine delivery and uptake in the placenta for healthier pregnancies Problem: The placenta is an important biological barrier that connects the mother and fetus while keeping their blood supplies separate, enabling nutrient and oxygen delivery and waste removal for healthy development. Abnormal...
Published: 5/8/2026
|
Updated: 5/8/2026
|
Inventor(s):
Michael Mitchell
,
Hannah Safford
,
Kelsey Swingle
,
Hannah Geisler
Keywords(s):
Bioengineering
,
Drug Delivery
,
Gene Therapy
,
Immunology
,
Immunotherapy
,
Women's Health
Category(s):
Technology Classifications > Therapeutics
Targeted Nanoparticle-Mediated HIF Stabilization in Myeloid Cells for Enhanced Transplant Tolerance
SHORT DESCRIPTION A PEG-PPS nanoparticle technology for targeted delivery of roxadustat to myeloid cells to promote transplantation tolerance. INVENTORS Edward Thorp* Northwestern University Feinberg School of Medicine, Department of Pathology Evan Scott* McCormick School of Engineering, Department...
Published: 6/16/2026
|
Updated: 5/7/2026
|
Inventor(s):
Keywords(s):
BIO2026
,
Drug delivery
,
Immunotherapy
,
Nanoparticle
,
Therapeutics
,
Tolerance induction
,
Transplantation
Category(s):
Life Sciences > Therapeutics
Targeting Autoimmunity-Associated T cells via AHR Pathway Control
SHORT DESCRIPTION Use of AHR agonists to inhibit pathogenic Tfh/Tph cell differentiation, potentially reducing disease activity. INVENTORS Jaehyuk Choi* Northwestern University Feinberg School of Medicine, Department of Dermatology **(Now at UT Southwestern)** Deepak Rao Brigham and Women's...
Published: 6/16/2026
|
Updated: 5/7/2026
|
Inventor(s):
Keywords(s):
Autoimmune disease
,
BIO2026
,
Immunology
,
Immunotherapy
,
Inflammation
,
RA - Rheumatoid arthritis
,
SLE - Systemic lupus erythematosus
,
Small molecule
,
Therapeutics
Category(s):
Life Sciences > Therapeutics
STING Agonist 8803 for Blood-Brain Barrier Opening in Glioblastoma Treatment
SHORT DESCRIPTION Chemical compound that opens the blood-brain barrier to enhance delivery of therapeutics for treating glioblastoma. INVENTORS Amy Heimberger* Northwestern University Feinberg School of Medicine, Department of Neurological Surgery * Principal Investigator NU Tech ID: NU 2025-212 IP...
Published: 6/16/2026
|
Updated: 4/27/2026
|
Inventor(s):
Keywords(s):
AD - Alzheimer’s Disease
,
Adjunct therapy
,
ALS - Amyotrophic Lateral Sclerosis
,
Animal Model
,
Autoimmune disease
,
BIO2026
,
Bladder cancer
,
Brain cancer
,
Breast cancer
,
Cancer Treatment
,
Cancer/Oncology
,
Cervical cancer
,
CNS - Central Nervous System
,
Colon cancer
,
Drug delivery
,
Endometrial cancer
,
Gastric cancer
,
GBM - Glioblastoma
,
Head and neck cancer
,
Immunology
,
Immunotherapy
,
Liver cancer
,
Lung cancer
,
MS - Multiple Sclerosis
,
Neurodegenerative disease
,
Neurologic disease
,
Ovarian cancer
,
Pancreatic cancer
,
PD - Parkinson's Disease
,
Prostate cancer
,
Repurposed Drugs
,
Research tool
,
Small molecule
,
Targeted therapy
,
TBI - Traumatic brain injury
,
Therapeutics
Category(s):
Life Sciences > Therapeutics
,
Life Sciences > Biomarkers & Biomedical Research Tools
1
2
3
4
5
6
7
8
9
10
...